These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4542103)

  • 21. Interrelations of the search for naturally-occurring goitrogens to the treatment of thyrotoxicosis.
    Greer MA
    N Z Med J; 1974 Dec; 80(529):493-4. PubMed ID: 4141488
    [No Abstract]   [Full Text] [Related]  

  • 22. [131-I capture by the thyroid gland during and after stopping thyrostatic treatment in thyrotoxicosis].
    Lozanov B; Vurbanov V; Baleva R
    Vutr Boles; 1975; 14(3):103-10. PubMed ID: 775786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of arterial pressure in patients with hyperthyroidism during therapy.
    Marcisz C; Jonderko G; Kucharz E
    Med Sci Monit; 2002 Jul; 8(7):CR502-7. PubMed ID: 12118198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism.
    Gesing J; Hoppmann J; Gebauer R; Pfäffle R; Bertsche A; Kiess W
    Pediatr Cardiol; 2018 Dec; 39(8):1707-1716. PubMed ID: 30242442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of thyroid function during and after treatment of thyrotoxicosis.
    McLarty DG; Alexander WD
    J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs.
    Refetoff S; Ochi Y; Selenkow HA; Rosenfield RL
    J Pediatr; 1974 Aug; 85(2):240-4. PubMed ID: 4135477
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.
    Reichert LJ; de Rooy HA
    BMJ; 1989 Jun; 298(6687):1547-8. PubMed ID: 2547467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Duration of drug therapy for hyperthyroidism. Suppressibility of thyroid function a criterion for remission?].
    Foldenauer A; Böhm P
    Dtsch Med Wochenschr; 1972 Apr; 97(15):604-6. PubMed ID: 5026796
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical treatment of Graves' disease. Long term results (author's transl)].
    Boulard C; Louvet JP; Daumas S; Vallee I; Lapebie P
    Ann Endocrinol (Paris); 1980; 41(6):585-9. PubMed ID: 6894678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine.
    Yamamoto M; Igarashi T; Kimura S; Tsukamoto S; Togawa K; Ogata E
    J Clin Endocrinol Metab; 1979 Jan; 48(1):72-7. PubMed ID: 581766
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroid function and dysfunction during pregnancy.
    Selenkow HA; Birnbaum MD; Hollander CS
    Clin Obstet Gynecol; 1973 Sep; 16(3):66-108. PubMed ID: 4204380
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selenium analogues of antithyroid drugs--recent developments.
    Roy G; Mugesh G
    Chem Biodivers; 2008 Mar; 5(3):414-39. PubMed ID: 18357551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithyroid-thyroid therapy for thyrotoxicosis.
    Selenkow HA
    JAMA; 1970 Dec; 214(12):2198. PubMed ID: 4098344
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lithium in the treatment of thyrotoxicosis (clinico-biological aspects)].
    Petrov NM; Semenov VV
    Probl Endokrinol (Mosk); 1986; 32(2):83-6. PubMed ID: 2424005
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease.
    Vitti P; Rago T; Mancusi F; Pallini S; Tonacchera M; Santini F; Chiovato L; Marcocci C; Pinchera A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):128-31. PubMed ID: 1543017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid-antithyroid therapy of thyrotoxicosis.
    Green WL; Danowski TS
    JAMA; 1971 May; 216(9):1484-5. PubMed ID: 4102939
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperthyroidism and excessive thyrotropin secretion.
    Emerson CH; Utiger RD
    N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
    [No Abstract]   [Full Text] [Related]  

  • 40. [Four-year follow-up of thyrotoxic patients treated with antithyroid drugs bases on thyroid suppressibility-Prognostic value of the 20-min 131-I thyroid uptake (author's transl)].
    Leclere J; Ueda M; Hartemann P; Maureira JJ; Mizrahi R; Zannetti A; Weyland M; Vaillant D
    Ann Endocrinol (Paris); 1980; 41(2):95-105. PubMed ID: 6162414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.